Previous 10 | Next 10 |
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 148 weeks of public selections as part of this ongoing live forward-testing. In...
Dynatronics (NASDAQ: DYNT ) +224% . More news on: Dynatronics Corporation, Altimmune, Inc., Allied Healthcare Products, Inc., Stocks on the move, , Read more ...
Allied Healthcare Products (NASDAQ: AHPI ) +71% . More news on: Allied Healthcare Products, Inc., GAIN Capital Holdings, Inc., Co-Diagnostics, Inc., Stocks on the move, , Read more ...
CINCINNATI, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), following the extremely successful launch of the Lyo-Ready qPCR mixes, is proud to introduce today its Air-Dryable qPCR Mix. This specialized master mix offers a cost-effective and easier alternative to ...
Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q1 2020 Earnings Call Feb 7, 2020 , 10:00 a.m. ET Operator Continue reading
Meridian Bioscience, Inc. (VIVO) Q1 2020 Earnings Conference Call February 07, 2020, 10:00 ET Company Participants Bryan Baldasare - EVP, CAO, CFO & Secretary John Kenny - President & CEO Conference Call Participants William Quirk - Piper Sandler & Co. Andrew Br...
The following slide deck was published by Meridian Bioscience, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Meridian Bioscience (NASDAQ: VIVO ): Q1 Non-GAAP EPS of $0.10 beats by $0.04 ; GAAP EPS of $0.07 beats by $0.01 . More news on: Meridian Bioscience, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CINCINNATI, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2019. First Quarter Fiscal 2020 Highlights: Diagnostics segment delivered nearly $35 million in revenues; fourth consecuti...
Cincinnati-based Meridian Bioscience (NASDAQ: VIVO) would seem to be an unlikely player in the global coronavirus fight. This week, however, the company announced that one of its reagents is being used in the development of molecular diagnostics for that virus. Because the reagen...
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that, at the special meeting of the shareholders of VIVO (the " Shareholders ") held today (the " Meeting "), the Shareholders approved (i) a special resolutio...